Disclosures related to prescription drugs.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 13 Sponsors

Jan 28, 2026 · House

First reading: referred to Committee on Public Health

Jan 27, 2026 · Senate

Referred to the House

Jan 26, 2026 · Senate

Third reading: passed; Roll Call 72: yeas 44, nays 0

Jan 26, 2026 · Senate

Senator Crider added as second author

Jan 26, 2026 · Senate

House sponsor: Representative Goss-Reaves

Jan 26, 2026 · Senate

Cosponsor: Representative Barrett

Jan 22, 2026 · Senate

Second reading: amended, ordered engrossed

Jan 22, 2026 · Senate

Amendment #1 (Bohacek) prevailed; voice vote

Jan 15, 2026 · Senate

Senator Randolph added as coauthor

Jan 15, 2026 · Senate

Committee report: amend do pass, adopted

Jan 6, 2026 · Senate

Senator Jackson L added as coauthor

Jan 5, 2026 · Senate

First reading: referred to Committee on Insurance and Financial Institutions

Jan 5, 2026 · Senate

Authored by Senator Bohacek

PASSAGE PROBABILITY

15.3% Unlikely

Why this number

Stage base Passed First Chamber — base rate 34%, measured from IN's completed sessions
Momentum +4 66/100 from the pace of recorded action
Time since last action -22 255 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.